ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer: first human trial of AND019 begins
Disease control Recruiting nowThis early-phase study tests a new drug called AND019 in postmenopausal women with a specific type of advanced breast cancer (ER-positive, HER2-negative) that has not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if …
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE1 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated May 17, 2026 05:04 UTC
-
New combo pill aims to outsmart BRCA breast cancer
Disease control Recruiting nowThis study tests whether adding a new oral drug (elacestrant) to standard olaparib can help people with a specific type of advanced breast cancer (HR+, HER2-, with BRCA1/2 mutations) live longer without the disease getting worse. About 176 participants will receive either the com…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: GBG Forschungs GmbH • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC